- Home
- SQNS vs VTGN Comparison
SQNS vs VTGN Comparison
Compare SQNS & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- VTGN
- Stock Information
- Founded
- SQNS 2003
- VTGN 1998
- Country
- SQNS France
- VTGN United States
- Employees
- SQNS N/A
- VTGN N/A
- Industry
- SQNS Semiconductors
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- VTGN Health Care
- Exchange
- SQNS Nasdaq
- VTGN Nasdaq
- Market Cap
- SQNS 85.7M
- VTGN 82.7M
- IPO Year
- SQNS 2011
- VTGN N/A
- Fundamental
- Price
- SQNS $2.09
- VTGN $2.51
- Analyst Decision
- SQNS Strong Buy
- VTGN
- Analyst Count
- SQNS 1
- VTGN 0
- Target Price
- SQNS $7.50
- VTGN N/A
- AVG Volume (30 Days)
- SQNS 71.6K
- VTGN 123.9K
- Earning Date
- SQNS 02-11-2025
- VTGN 02-13-2025
- Dividend Yield
- SQNS N/A
- VTGN N/A
- EPS Growth
- SQNS N/A
- VTGN N/A
- EPS
- SQNS 2.00
- VTGN N/A
- Revenue
- SQNS $36,762,000.00
- VTGN $698,000.00
- Revenue This Year
- SQNS N/A
- VTGN N/A
- Revenue Next Year
- SQNS $95.51
- VTGN N/A
- P/E Ratio
- SQNS $1.04
- VTGN N/A
- Revenue Growth
- SQNS 9.36
- VTGN N/A
- 52 Week Low
- SQNS $0.85
- VTGN $2.22
- 52 Week High
- SQNS $4.28
- VTGN $5.74
- Technical
- Relative Strength Index (RSI)
- SQNS 32.91
- VTGN 39.56
- Support Level
- SQNS $2.10
- VTGN $2.58
- Resistance Level
- SQNS $2.49
- VTGN $2.69
- Average True Range (ATR)
- SQNS 0.15
- VTGN 0.16
- MACD
- SQNS 0.00
- VTGN -0.02
- Stochastic Oscillator
- SQNS 14.89
- VTGN 15.09
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.